VM202: Clinical Trials

3 trials of VM202, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 23Completed 2, Withdrawn 1

Follow VM202: new trials by email Literature Review of VM202 trials Research Report on VM202

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene Therapy for the Treatment of Chronic Stable Angina
VM202 - Myocardial Ischemia
Phase 1 / Phase 2WithdrawnHelixmith Co., Ltd.2015-03-012025-09-25
Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
VM202 - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2CompletedHelixmith Co., Ltd.182014-03-112025-10-06
Gene Therapy for Painful Diabetic Neuropathy
VM202 - Painful Diabetic Peripheral Neuropathy
Phase 1 / Phase 2CompletedHelixmith Co., Ltd.122010-02-012025-10-06

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Angina Pectoris (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Ischemia (1)  ·  Myocardial Ischemia (1)  ·  Neurodegenerative Diseases (1)

Sponsors

Helixmith Co., Ltd. (3)

Countries

United States (3)

Top investigators

John A Kessler, MD (1)  ·  John Kessler, M.D. (1)